Exane Derivatives’s BROADCOM CORP CL-A BRCM Stock Holding History

Exane Derivatives’s Portfolio BRCM Stock Details BRCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-229	Closed	-$13.2K	–	628
2015 Q4	$13.2K	Buy	229 +220	+2,444%	+$11.8K	﹤0.01%	316
2015 Q3	$463	Hold	9	–	–	﹤0.01%	450
2015 Q2	$463	Hold	9	–	–	﹤0.01%	461
2015 Q1	$390	Sell	9 -12	-57%	-$523	﹤0.01%	468
2014 Q4	$910	Buy	+21	New	+$860	﹤0.01%	478

Other funds holding BRCM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MAM

Mizuho Asset Management Tokyo, Japan $462M AUM 15.39% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Exane Derivatives's BRCM Position: Q1 2016 in Review

Exane Derivatives sold out of BROADCOM CORP CL-A (BRCM) in Q1 2016, closing a stake of 229 shares — an estimated $13.2K sold.

Exane Derivatives first reported a position in BRCM in Q4 2014 and held it in 5 quarters. The position peaked at $13.2K in Q4 2015. 6 funds tracked by Wall St. Rank hold BRCM as of Q1 2016.

Exane Derivatives reported no remaining BROADCOM CORP CL-A position as of Q1 2016 after selling out during the quarter.
Exane Derivatives sold 229 BROADCOM CORP CL-A shares in Q1 2016, an estimated $13.2K.
Exane Derivatives first reported a position in BROADCOM CORP CL-A in Q4 2014 and held it in 5 quarters.
Exane Derivatives's BROADCOM CORP CL-A position peaked at $13.2K in Q4 2015.
6 funds tracked by Wall St. Rank held BROADCOM CORP CL-A as of Q1 2016.

Based on Exane Derivatives's 13F filing for Q1 2016, filed 4 May 2016.